Skip to content

Cogent Biosciences, Inc.

COGT

CIK 0001622229

← back to feed
Revenue (TTM)
$8.89M
−48.5% YoY Q1 May 2026
Net Income (TTM)
−$323.8M
−28.6% YoY Q1 May 2026
EPS Diluted (TTM)
−$2.08
−11.3% YoY Q1 May 2026
Gross Margin
—
Q1 May 2026
Operating Margin
-3,795.7%
Q1 May 2026
Net Margin
-3,641.9%
Q1 May 2026
Free Cash Flow (TTM)
−$247.61M
Q1 May 2026
Cash
$241.21M
Q1 May 2026
Total Debt
$44.25M
Q1 May 2026
Shares Outstanding
170.87M sh
Q1 May 2026

Revenue & Net Income

EPS (Diluted)

Margins

Cash Flow

Revenue Growth (YoY)

Balance Sheet

Cash vs Debt

Recent filings